2021
DOI: 10.1002/jcla.24191
|View full text |Cite
|
Sign up to set email alerts
|

Biochemical testing for the diagnosis of Wilson's disease: A systematic review

Abstract: This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
12
0
2

Year Published

2021
2021
2024
2024

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 9 publications
(14 citation statements)
references
References 22 publications
0
12
0
2
Order By: Relevance
“…For this reason, even analyses with the most advanced technologies, including next-generation sequencing, require additional tests, including biochemical evidence of abnormal copper metabolism, to confirm the diagnosis of WND [ 32 ].…”
Section: Resultsmentioning
confidence: 99%
“…For this reason, even analyses with the most advanced technologies, including next-generation sequencing, require additional tests, including biochemical evidence of abnormal copper metabolism, to confirm the diagnosis of WND [ 32 ].…”
Section: Resultsmentioning
confidence: 99%
“…It first develops superiorly, then inferiorly, and, finally, in the lateral and medial areas of the cornea. These occur in approximately 40% of patients with hepatic manifestations and in about 95% of patients with neurologic manifestations [ 8 , 17 , 18 ].…”
Section: Wilson’s Disease (Hepatolenticular Degeneration Omim #27790)mentioning
confidence: 99%
“…Both the clinical picture and laboratory test results are not specific to Wilson’s disease. The most important tests in the diagnostics of Wilson’s disease involve the concentration levels of ceruloplasmin in the blood plasma, 24 h urinary copper excretion, and molecular tests [ 10 , 15 , 17 , 18 , 19 , 20 , 21 , 22 ].…”
Section: Wilson’s Disease (Hepatolenticular Degeneration Omim #27790)mentioning
confidence: 99%
“…Обследовано 53 пациента с болезнью Вильсона-Коновалова, в возрасте от 6 до 18 лет Ме 14,1 (11,(0)(1)(2)(3)(4)(5)(6)(7)(8)(9)(10)(11)(12)(13)(14)(15)(16)6). Все дети находились на стационарном лечении в гастроэнтерологическом отделении с гепатологической группой ФГАУ «НМИЦ здоровья детей» Минздрава России.…”
Section: материалы и методыunclassified
“…Для болезни Вильсона-Коновалова характерны: лейкопения, нормохромная анемия, тромбоцитопения, снижение церулоплазмина и общей меди, гипоальбуминемия, увеличение уровней аминотрасфераз (в 1,5-50 раз), билирубина, щелочной фосфатазы, гаммаглютамилтранспептидазы [3,13]. Особое внимание отводится определению меди в моче: гиперкупренилурия у пациентов с болезнью Вильсона-Коновалова может достигать более 1500 мкг/сут (норма < 50 мкг/сут) [9,13]. Токсическое действие меди на ткань печени может проявляться в форме жировой дистрофии гепатоцитов, гепатита, фиброза и цирроза печени [7,14].…”
Section: Introductionunclassified